2016
DOI: 10.1007/s00384-016-2502-0
|View full text |Cite
|
Sign up to set email alerts
|

Complete mesocolic excision and extended (D3) lymphadenectomy for colonic cancer: is it worth that extra effort? A review of the literature

Abstract: Although there is a reasonable anatomical and oncological basis for these techniques, there are no randomised controlled trials from which to draw confident conclusions and there is insufficient consistent high quality evidence to recommend widespread adoption of CME.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
40
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(41 citation statements)
references
References 75 publications
0
40
0
1
Order By: Relevance
“…There is general consensus in the western world that the resection should be performed in the mesocolic (embryological) plane, but it is the importance of central ligation of the tumour feeding vessel that is still debated [18]. Concerns have also been raised about potentially increased morbidity from high ligation [16,19].…”
Section: Discussionmentioning
confidence: 99%
“…There is general consensus in the western world that the resection should be performed in the mesocolic (embryological) plane, but it is the importance of central ligation of the tumour feeding vessel that is still debated [18]. Concerns have also been raised about potentially increased morbidity from high ligation [16,19].…”
Section: Discussionmentioning
confidence: 99%
“…The concept of CME introduced standardized colon cancer surgery with resection in the mesocolic plane and central ligation of the tumor feeding vessel [1]. In recent years, there has been significant debate about the clinical benefit of CME surgery and specifically mandatory division of the tumor feeding artery remains controversial [5,6].…”
Section: Discussionmentioning
confidence: 99%
“…Colorectal cancer (CRC) is the third most common diagnosis and second deadliest malignancy for both sexes combined [1]. Many therapeutic strategies, such as surgery, chemotherapy, and radiotherapy, are used to treat CRC, and radiotherapy combined with chemotherapy is the standard of care in locally advanced rectal cancer in the setting of neoadjuvant treatment, but the outcome remains suboptimal for advanced cases.…”
Section: Introductionmentioning
confidence: 99%